Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer

Condition:   Endometrial CancerInterventions:   Drug: cediranib maleate;   Other: laboratory biomarker analysisSponsors:   Gynecologic Oncology Group;   National Cancer Institute (NCI)Recruiting - verified August 2010